Key Highlights
● Gevo swung to a $176.9 million GAAP net loss on an ATJ-60 Impairment but raised full-year 2026 adjusted EBITDA guidance to more than $60 million as it pivots toward monetizing Section 45Z and Canadian Clean Fuel credits.
● Innospec posted second-quarter Revenue of $491.4 million, up 12%, with $250.2 million in cash and no debt, giving it the strongest Balance Sheet of the group.
● Alico wound down its citrus operations and swung to $10.0 million of Net Income largely on land sales, reframing itself as a land and real-estate story rather than an agriculture producer.
● Village Farms grew cannabis revenue to about $53.5 million with international export cannabis up 74% to a record $20.9 million, delivering a fifth consecutive profitable quarter.
A renewable-fuels turnaround story, a corrosion-materials compounder, a debt-free specialty chemicals cash machine, a land-and-real-estate outlier and a cannabis grower all sit on the same Nasdaq screen this September. Here is what the numbers actually say heading into autumn 2026.
Five Very Different Ways to Play Materials and Process
The phrase materials and process industries hides enormous variety, and this five-stock cluster proves the point. Gevo makes low-carbon fuels. Northern Technologies sells rust prevention and bioplastics. Innospec is a diversified specialty chemicals house. Alico has walked away from oranges to become a Florida land company. Village Farms grows greenhouse produce and cannabis.
A mixed basket like Gevo (NASDAQ: GEVO), Northern Technologies (NASDAQ: NTIC), Innospec (NASDAQ: IOSP), Alico (NASDAQ: ALCO) and Village Farms (NASDAQ: VFF) does not share a Business model, but the five do share a moment: each has just reported results that reset expectations, and each sits at a policy or capital-allocation inflection. The analysis below is built on the most recent company disclosures, with every figure sourced to a filing or release.
The Sector Backdrop: Policy Is the Swing Factor
Two forces dominate this corner of the market right now. The first is US fuels policy. The 2025 reconciliation law reshaped the Section 45Z Clean Fuel Production Credit, and Treasury and the IRS issued further Section 45Z guidance published in the Federal Register in February 2026. Policy coverage from late 2025 noted the law expanded 45Z support for conventional biofuels while trimming the sustainable aviation fuel premium. That matters directly for renewable-fuels economics.
The second force is Demand normalization across industrial chemicals and materials after several volatile years. Specialty chemical volumes, corrosion-protection spending tied to Manufacturing and energy activity, and controlled-environment agriculture pricing are all cyclical. The companies here are being judged less on top-line growth alone than on Margin quality, balance-sheet strength and the credibility of their next strategic step.
Gevo (NASDAQ:GEVO): A Renewable-Fuels Story Pivoting on Carbon and Credits
Gevo is the most speculative name in the group and also the one with the clearest catalysts. For the second quarter of 2026, Gevo reported revenue of $46.5 million, up from $43.4 million a year earlier, alongside a GAAP net loss of $176.9 million, or $(0.75) per share, driven largely by an approximately $176 million impairment tied to exiting its ATJ-60 project. Stripping that out, non-GAAP adjusted EBITDA was roughly $11 million, and management raised full-year 2026 adjusted EBITDA guidance to more than $60 million, up from a prior target of about $30 million.
The pivot is toward monetizing carbon and tax credits rather than chasing capital-heavy new-build sustainable aviation fuel. Gevo cited a target of monetizing over $70 million of Section 45Z credits in 2026 and a Canadian Clean Fuel Regulation pathway approval expected to support third-quarter revenue. Its North Dakota assets, including planned expansion toward roughly 150 million gallons annually with carbon capture and a targeted 2028 startup, anchor the longer-term case.
The risk is stark. Gevo held $58.1 million of cash against $167.2 million of loans payable at 30 June 2026. Execution and Credit monetization, not the guidance slide deck, will decide how 2026 closes out for the company.
Northern Technologies (NASDAQ:NTIC): Quiet Compounder in Corrosion and Bioplastics
Northern Technologies is the small-cap materials specialist here, built around its ZERUST corrosion-inhibiting products and Natur-Tec compostable bioplastics. For its fiscal second quarter ended 28 February 2026, the company reported record consolidated net sales of about $22.0 million, up 15.3% year over year.
The mix is encouraging. ZERUST industrial sales rose 11.2% to roughly $14.0 million, ZERUST oil and gas jumped 72.1% to about $2.7 million, a second-quarter record, and Natur-Tec grew 8.1% to roughly $5.4 million, about a quarter of total sales. Total income from joint-venture operations rose 19.8% to about $2.0 million, and gross margin held at 35.7%.
The catch is profitability at the bottom line. Northern Technologies recorded a net loss attributable to the company of about $35,000, or $(0.00) per diluted share, versus net income a year earlier, as spending outpaced the sales gain. Management guided to continued growth and improved profitability in the fiscal second half. For a business this small, the question is whether Operating Leverage finally shows up.
Innospec (NASDAQ:IOSP): The Debt-Free Cash Machine of the Group
Innospec is the quality anchor of the basket. For the second quarter of 2026 the specialty chemicals maker reported total revenue of $491.4 million, up 12% year over year, net income attributable to Innospec of $30.8 million, and GAAP diluted EPS of $1.25, up from $0.94. Adjusted EBITDA came in at about $50.1 million.
Crucially, growth was broad. Performance Chemicals revenue rose 9% with Operating Income up 15%, Fuel Specialties revenue rose 12%, and Oilfield Services revenue rose 14% with operating income up 40%. That balance across three segments is exactly what a cyclical business wants to show late in a recovery.
The balance sheet is the headline. Innospec finished the quarter with $250.2 million in cash and no debt, while continuing to return Capital through a semi-annual Dividend of $0.92 per share and buybacks. A debt-free chemicals company generating this level of cash has real optionality for acquisitions or larger returns. The item worth watching is whether adjusted EPS, roughly flat year over year despite revenue growth, reflects mix and reinvestment or the early edge of margin pressure.
Alico (NASDAQ:ALCO): The Honest Outlier That Is No Longer Really an Agriculture Stock
Alico belongs on this list with a clear caveat: it is now a land and real-estate story, not a citrus grower. The company wound down its Alico Citrus division after completing the 2024-2025 harvest in April 2025, and citrus revenues collapsed accordingly.
The numbers reflect a business in transition. For the nine months ended 30 June 2026, total operating revenues fell 62.4% to $16.3 million, yet Alico swung to net income attributable to common stockholders of $10.0 million, or $1.33 per basic share, versus a large prior-year loss, helped by land transactions. During the period it sold roughly 3,546 acres for about $34.6 million.
What investors are really buying is the land itself: roughly 47,300 acres owned plus about 42,700 acres of mineral rights, with land-management revenues up more than fourfold and a stated pivot toward land management and real-estate development. Alico ended the period with $55.6 million cash against $29.8 million net debt. This is a break-up-value and entitlement play, and it should be framed that way rather than as a produce company.
Village Farms (NASDAQ:VFF): From Greenhouse Produce to a Profitable Cannabis Exporter
Village Farms rounds out the group as the controlled-environment agriculture name. For the second quarter of 2026 it reported total revenue of about $64.0 million, up 7%, with net income of $7.15 million, or $0.06 per diluted share, marking a fifth consecutive profitable quarter.
Cannabis is now the engine. Cannabis revenue was about $53.5 million, and cannabis adjusted EBITDA from continuing operations was roughly $15.3 million at a 28.5% margin, with cannabis gross margin expanding to 51% from 42% a year earlier. The standout was international export cannabis of about $20.9 million, a record and up 74% year over year, with management pointing to European strength, particularly Germany. Canadian branded cannabis contributed about $23.0 million and fresh produce about $10.2 million.
The company ended the quarter with about $72.9 million cash and completed a $15 million registered direct Equity offering, while flagging Delta 2 expansion toward 40-tonne capacity by mid-2027. The export ramp is the catalyst; regulatory shifts and equity dilution are the risks.
What Investors Should Watch
For Gevo, the near-term tell is cash: whether 45Z credit monetization and Canadian volumes convert guidance into real inflows before the balance sheet tightens. For Northern Technologies, watch fiscal second-half profitability and whether oil-and-gas and Natur-Tec momentum drops to the bottom line.
For Innospec, the questions are capital deployment of that debt-free cash pile and any sign of margin fatigue. For Alico, the pace and pricing of land monetization is now the entire thesis. For Village Farms, international export durability and cannabis margin trajectory matter most, alongside dilution risk.
Across all five, US fuels and agriculture policy remains the shared macro variable, and any further 45Z or sustainable aviation fuel rule-making could move the renewable-fuels names sharply. Liquidity is a practical filter too: several of these names are small enough that a single Earnings surprise or capital-raise headline can swing the price more than the underlying fundamentals justify.
One Ticket, Five Completely Different Businesses
This basket resists a single trade thesis because the five companies simply do not compete on the same terms. Innospec offers the strongest balance sheet and the steadiest profile of the group. Village Farms has turned genuinely profitable on cannabis exports rather than produce. Northern Technologies is a growth-with-margin question mark waiting on operating leverage. Alico is a land-value special situation dressed in an agriculture ticker. Gevo is a high-risk, catalyst-driven turnaround that lives or dies on credit monetization.
What connects them is timely, verifiable news flow rather than a shared sector narrative. Innospec's cash pile and Village Farms' export growth argue for patience, while Gevo's Loan balance and Alico's dependence on land sales argue for closer attention to each coming quarter.






Please wait processing your request...